| Goodwill and Intangible Assets Disclosure [Text Block] |
Note 5 – Goodwill and intangible assets
At April 30, 2017 and July 31, 2016, the Company’s net
carrying amount of goodwill, related to the Clinical Labs segment, is $7,452.
The Company’s change in the net carrying amount of intangible
assets, all in the Life Sciences segment is as follows:
| |
|
Gross |
|
|
Accumulated
Amortization |
|
|
Net |
|
| July 31, 2016 |
|
$ |
27,650 |
|
|
$ |
(23,228 |
) |
|
$ |
4,422 |
|
| Amortization expense |
|
|
— |
|
|
|
(1,140 |
) |
|
|
(1,140 |
) |
| Foreign currency translation |
|
|
(159 |
) |
|
|
121 |
|
|
|
(38 |
) |
| April 30, 2017 |
|
$ |
27,491 |
|
|
$ |
(24,247 |
) |
|
$ |
3,244 |
|
Intangible assets, all finite lived, consist of the following:
| |
|
April
30, 2017 |
|
|
July
31, 2016 |
|
| |
|
Gross |
|
|
Accumulated
Amortization |
|
|
Net |
|
|
Gross |
|
|
Accumulated
Amortization |
|
|
Net |
|
| Patents |
|
$ |
11,027 |
|
|
$ |
(10,931 |
) |
|
$ |
96 |
|
|
$ |
11,027 |
|
|
$ |
(10,905 |
) |
|
$ |
122 |
|
| Customer
relationships |
|
|
12,034 |
|
|
|
(8,948 |
) |
|
|
3,086 |
|
|
|
12,122 |
|
|
|
(8,331 |
) |
|
|
3,791 |
|
| Website and acquired content |
|
|
1,006 |
|
|
|
(1,006 |
) |
|
|
— |
|
|
|
1,011 |
|
|
|
(1,011 |
) |
|
|
— |
|
| Licensed technology and other |
|
|
481 |
|
|
|
(450 |
) |
|
|
31 |
|
|
|
485 |
|
|
|
(437 |
) |
|
|
48 |
|
| Trademarks |
|
|
2,943 |
|
|
|
(2,912 |
) |
|
|
31 |
|
|
|
3,005 |
|
|
|
(2,544 |
) |
|
|
461 |
|
| Total |
|
$ |
27,491 |
|
|
$ |
(24,247 |
) |
|
$ |
3,244 |
|
|
$ |
27,650 |
|
|
$ |
(23,228 |
) |
|
$ |
4,422 |
|
At April 30, 2017, information with respect to intangibles assets
acquired is as follows:
| |
|
|
Useful
life
assigned
|
|
|
|
Weighted
average
remaining
useful life
|
|
| Customer relationships |
|
|
8-15
years |
|
|
|
3.5
years |
|
| Trademarks |
|
|
5
years |
|
|
|
0.5
year |
|
| Other intangibles |
|
|
10
years |
|
|
|
2.5
years |
|
At April 30, 2017, the weighted average useful life of intangible
assets is approximately three years.
|